AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7844609
Drug: IL-1 beta
RxNorm normalized name: Heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IGg1 and part of human IL1 receptor accessory protein
DrugBank: Goflikicept (DB16396)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-1 beta (0.005 to 0.2 micrograms/kg/d) combined with IL-2 (0.1 mg/m2/d)
Trial: 7844609
Drug: IL-1 beta
RxNorm normalized name: Heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IGg1 and part of human IL1 receptor accessory protein
DrugBank: Goflikicept (DB16396)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-1 beta (0.005 to 0.05 micrograms/kg/d) combined with IL-2 (0.1 mg/m2/d)
Trial: 7844609
Drug: IL-1 beta
RxNorm normalized name: Heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IGg1 and part of human IL1 receptor accessory protein
DrugBank: Goflikicept (DB16396)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-1 beta (0.1 to 0.2 micrograms/kg/d) combined with IL-2 (0.1 mg/m2/d)
Trial: 2309545
Drug: Intramuscular pethidine
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pethidine (75 mg)
Trial: 393363
Drug: Minocycline 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 300 mg
Trial: 393363
Drug: Ampicillin 2
RxNorm normalized name: ampicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 2 g and probenecid 1 g
Trial: 31770617
Drug: Preventive treatment
RxNorm normalized name: STANNOUS FLUORIDE 0.004 g in 1 g DENTAL GEL [Enamelon Preventive Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive treatment with rifapentine and isoniazid
Trial: 23499158
Drug: Sofosbuvir 200
RxNorm normalized name: sofosbuvir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 200 mg + peginterferon + ribavirin
Trial: 23499158
Drug: Sofosbuvir 400
RxNorm normalized name: sofosbuvir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 400 mg + peginterferon + ribavirin
Trial: 23499158
Drug: Sofosbuvir 400
RxNorm normalized name: sofosbuvir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 400 mg + peginterferon + ribavirin (cohort B)
Trial: 19585548
Drug: High-dose ursodeoxycholic
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ursodeoxycholic acid (UDCA) (28-30 mg/kg/day)
Trial: 19585548
Drug: High-dose ursodeoxycholic
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ursodeoxycholic acid (UDCA)
Trial: 17919823
Drug: Dacarbazine monotherapy
RxNorm normalized name: Dacarbazine
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dacarbazine monotherapy
Trial: 17919823
Drug: Other treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatments (alone or in combination)
Trial: 15372386
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine in 20 mL of 0.9% NaCl solution (5 mL of solution per point) 10 minutes before the operation (Group M)
Trial: 15372386
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 0.25% bupivacaine (Group B)
Trial: 15372386
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine in 20 mL of 0.25% bupivacaine (Group M+B)
Trial: 15372386
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 0.9% NaCl (Group S)
Trial: 15372386
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 0.9% NaCl with 2 mg of subcutaneous morphine 10 minutes before surgery (Group S+M)
Trial: 18980474
Drug: Thyrotropin releasing
RxNorm normalized name: Thyrotropin releasing factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin releasing hormone
Trial: 1392111
Drug: Topical lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lithium succinate ointment (LSO)
Trial: 4002806
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg M/day
Trial: 4002806
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg M/day
Trial: 27153158
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection of 9 µg of hemagglutinin (HA) per strain
Trial: 27153158
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 15 µg of HA per strain
Trial: 27153158
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection
Trial: 10217608
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection
Trial: 24461315
Drug: Cinnamon (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon (1500 mg daily)
Trial: 24461315
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 capsules daily)
Trial: 21049063
Drug: 20 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg/day of paromomycin for 21 days
Trial: 21049063
Drug: 15 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg/day of paromomycin for 28 days
Trial: 17984140
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 150 mg/kg on the first day followed by 50 mg/kg/day for three days
Trial: 11958351
Drug: Compound cue
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound cue AT followed by an outcome (AT+)
Trial: 12551863
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg BID)
Trial: 8961043
Drug: Fluoxetine (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (not specified dosage or duration)
Trial: 1761079
Drug: Eltoprazine HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Eltoprazine (DB12883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltoprazine HCl 5, 10, 20 mg
Trial: 1761079
Drug: Eltoprazine HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Eltoprazine (DB12883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltoprazine HCl 30 mg
Trial: 31980871
Drug: Diltiazem gel
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem gel 2%
Trial: 30922355
Drug: Binafuxi granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binafuxi granules (high-dose group)
Trial: 30922355
Drug: Binafuxi granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binafuxi granules (low-dose group)
Trial: 27601545
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy and 6 months of ADT
Trial: 19151384
Drug: Real therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real therapy
Trial: 17474541
Drug: Test syrup
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test syrup containing 15 mg dextromethorphan hydrobromide, 7.5 mg doxylamine succinate, 600 mg paracetamol, and 8 mg ephedrine sulfate (Group T)
Trial: 17474541
Drug: Placebo syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo syrup (Group P)
Trial: 17474541
Drug: Test syrup
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test syrup (Group T)
Trial: 348553
Drug: Milk B
RxNorm normalized name: Milk bread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk B (12.5 g of lactose)
Trial: 348553
Drug: Milk C
RxNorm normalized name: Milk casein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk C (37.5 g of lactose)
Trial: 16164475
Drug: Acupressure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure therapy
Trial: 21937521
Drug: Hyperthermia and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperthermia and Sham treatment
Trial: 17466110
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behaviour therapy
Trial: 17466110
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive behaviour therapy
Trial: 11529210
Drug: Prone positioning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prone positioning for six or more hours daily for 10 days
Trial: 11529210
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment in the supine position
Trial: 9096189
Drug: Rifabutin in
RxNorm normalized name: Product containing rifabutin in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin in combination with a macrolide antibiotic (clarithromycin or azithromycin)
Trial: 8329260
Drug: S(+)‐ketamine 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(+)‐ketamine 1 mg/kg body weight
Trial: 8329260
Drug: Racemic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic ketamine 2 mg/kg body weight
Trial: 30509638
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein meal with phosphorus (500 mg)
Trial: 30509638
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein meal with phosphorus (500 mg)
Trial: 24713309
Drug: Serial weekly
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serial weekly transabdominal amnioinfusion (AI)
Trial: 21143403
Drug: Modified-release paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified-release paracetamol (PEx) 80 mg/kg
Trial: 21143403
Drug: Immediate-release paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release paracetamol (APAP-IR) 80 mg/kg
Trial: 9833950
Drug: Oral N-acetyl-L-cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral N-acetyl-L-cysteine (1,200 mg/day)
Trial: 2518872
Drug: Antacid (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (one tablet q.d.s. for 1.5 days)
Trial: 2518872
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one tablet q.d.s. for 1.5 days)
Trial: 1053551
Drug: Sublingual isosorbide
RxNorm normalized name: isosorbide dinitrate Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual isosorbide dinitrate (SISD)
Trial: 29960290
Drug: Lianhuaqingwen capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lianhuaqingwen capsules
Trial: 16894335
Drug: ERr 731
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ERr 731 (one enteric-coated tablet daily for 12 weeks)
Trial: 8190435
Drug: Oxytocin augmentation
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin augmentation with intact chorioamnion
Trial: 8190435
Drug: Oxytocin augmentation
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin augmentation with amniotomy and internal monitoring
Trial: 18931095
Drug: Liraglutide 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 1.8 mg/day
Trial: 28094194
Drug: MABp1 (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MABp1 (7.5 mg/kg every 2 weeks for 8 weeks)
Trial: 19853417
Drug: Medication and
RxNorm normalized name: CVS Health Medication and Topical Refill Pouch KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication and Placebo
Trial: 16903245
Drug: Postpartum treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postpartum treatment (three months after delivery)
Trial: 11884000
Drug: Oral multivitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral multivitamins from the first day of admission
Trial: 2955324
Drug: Indomethacin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 0.1 mg/kg
Trial: 14602694
Drug: Indomethacin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 0.2 mg/kg
Trial: 26460504
Drug: Darunavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir monotherapy (DRV/r) 800/100 mg once daily for 48 weeks
Trial: 22739371
Drug: Cholecalciferol 15
RxNorm normalized name: Cholecalciferol 150 MCG/1 DRP Oral Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 15 μg/d (D3-15)
Trial: 22739371
Drug: Cholecalciferol 10
RxNorm normalized name: cholecalciferol 100 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 10 μg/d (D3-10)
Trial: 22739371
Drug: Cholecalciferol 5
RxNorm normalized name: cholecalciferol 50 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 5 μg/d (D3-5)
Trial: 22739371
Drug: Cholecalciferol 0
RxNorm normalized name: cholecalciferol 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 0 μg/d (P)
Trial: 22739371
Drug: Cholecalciferol (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol (any dose)
Trial: 18479176
Drug: Lornoxicam quick-release
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam quick-release tablet (QR)
Trial: 18479176
Drug: Lornoxicam standard
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam standard tablet (ST)
Trial: 18479176
Drug: Lornoxicam intramuscular
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam intramuscular injection (IM)
Trial: 16140282
Drug: Olanzapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (mean 11.30 mg/day)
Trial: 16140282
Drug: Haloperidol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (mean 4.87 mg/day)
Trial: 1422754
Drug: Lomoparan (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomoparan (750 anti-Xa units subcutaneously twice a day)
Trial: 1422754
Drug: Heparin-DHE 5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-DHE 5000 (5000 units heparin and 0.5 mg dihydroergotamine subcutaneously twice a day)
Trial: 1422754
Drug: Heparin-DHE 5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-DHE 5000
Trial: 6708033
Drug: Placebo (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5% dextrose in lactated Ringer's solution)
Trial: 12955901
Drug: Conventional medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medication
Trial: 29975203
Drug: Preoperative fascia
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative fascia iliaca block with 40 ml ropivacaine 0.2%
Trial: 16123896
Drug: Hymecromone 800
RxNorm normalized name: hymecromone
DrugBank: Hymecromone (DB07118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hymecromone 800 mg p.o. with standardized meal (Biloptin, 40 gs)
Trial: 12893113
Drug: Various antiepileptic
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various antiepileptic drugs used to treat seizure disorder
Trial: 12893113
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment of intractable epilepsy
Trial: 1995721
Drug: Rhesus rotavirus
RxNorm normalized name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension [Rotarix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhesus rotavirus vaccine (10^4 pfu)
Trial: 1995721
Drug: RIT 4237
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, RIT-4385 strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT 4237 vaccine (10^8 pfu)
Trial: 22575075
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg pregabalin
Trial: 30115911
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg pregabalin
Trial: 22575075
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg pregabalin
Trial: 22575075
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg pregabalin
Trial: 17436845
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy using a sensory integration approach (OT‐SI)
Trial: 15821119
Drug: Analgesic Protocol
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic Protocol (AP)
Trial: 7836622
Drug: Three different
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three different magnesium oxide preparations
Trial: 2873966
Drug: Endralazine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endralazine (10 mg to 30 mg per day)
Trial: 2873966
Drug: Hydralazine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (75 mg to 200 mg per day)
Trial: 16931259
Drug: Trypan blue
RxNorm normalized name: Trypan Blue
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trypan blue 0.0125% solution (Group 1, n = 20)
Trial: 16931259
Drug: No anterior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anterior capsule staining (Group 2, n = 20)
Trial: 10479911
Drug: Chemotherapy (ChT)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (ChT)
Trial: 22916226
Drug: Closantel treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closantel treatment at dry-off
Trial: 19147504
Drug: HSA+serum substitute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSA+serum substitute supplement (SSS)
Trial: 19147504
Drug: HSA (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSA (as the sole protein supplement)
Trial: 17971178
Drug: Low-carbohydrate diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-carbohydrate diet (<= 40 g carbohydrate/day)
Trial: 15609594
Drug: Xuefu Zhuyu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuefu Zhuyu decoction (XZD) with conventional liver protective treatment
Trial: 15609594
Drug: Conventional liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional liver protective treatment alone
Trial: 8895147
Drug: DP-1904 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DP-1904 (400 mg/day bid)
Trial: 8895147
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg/day bid)
Trial: 1806334
Drug: beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beclomethasone dipropionate 300 mcg/day
Trial: 6354522
Drug: Metoclopramide (MCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MCP) infusion during low sodium intake (10 mmol)
Trial: 6354522
Drug: Metoclopramide (MCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MCP) infusion during high sodium intake (200 mmol)
Trial: 30610213
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg curcumin
Trial: 26134371
Drug: Doxycycline therapy
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline therapy
Trial: 21725634
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 100 mg flurbiprofen axetil postoperative (Group B)
Trial: 21725634
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group A)
Trial: 21725634
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml placebo preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group C)
Trial: 18445098
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori screening and treatment
Trial: 16902311
Drug: Weekly or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly or more frequent monitoring
Trial: 12499335
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of supplement (200 mg vitamin E, 300 mg vitamin C, 25 mg beta-carotene, 90 micro g Se, and 500 micro g vitamin A)
Trial: 12499335
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of supplement (10 mg vitamin E and 500 micro g vitamin A)